---
author: []
related: []
publisher:
  url: 'http://www.investorideas.com'
  name: Investorideas
  favicon: 'http://www.investorideas.com/favicon.ico'
  domain: www.investorideas.com
keywords:
  - fy16
  - '2016'
  - million
  - mesoblast
  - phase
  - tier
  - fy15
  - products
  - trial
  - cash
description: >-
  Mesoblast (Nasdaq: $MESO) (ASX: $MSB) Reports Financial Results and
  Operational Highlights for the Three Months and for the Year Ended 30 June
  2016
inLanguage: en
app_links: []
isBasedOnUrl: 'http://www.investorideas.com/news/2016/biotech/08253MESO.asp'
title: >-
  Investorideas.com - Mesoblast (Nasdaq: $MESO) (ASX: $MSB) Reports Financial
  Results and Operational Highlights for the Three Months and for the Year Ended
  30 June 2016
datePublished: '2016-08-25T17:22:46.580Z'
dateModified: '2016-08-25T17:22:41.904Z'
via: {}
starred: false
sourcePath: >-
  _posts/2016-08-25-investorideascom-mesoblast-nasdaq-dollarmeso-asx-dollarmsb-re.md
inFeed: true
hasPage: false
inNav: false
_context: 'http://schema.org'
_type: MediaObject

---
<article style=""><h1>Investorideas.com - Mesoblast (Nasdaq: $MESO) (ASX: $MSB) Reports Financial Results and Operational Highlights for the Three Months and for the Year Ended 30 June 2016</h1><p>Mesoblast (Nasdaq: $MESO) (ASX: $MSB) Reports Financial Results and Operational Highlights for the Three Months and for the Year Ended 30 June 2016</p><img src="http://www.investorideas.com/news/2016/biotech/images/082516-3.jpg" /></article>